EA201490233A8 - Стабильные лекарственные формы артеролана и пиперахина - Google Patents

Стабильные лекарственные формы артеролана и пиперахина

Info

Publication number
EA201490233A8
EA201490233A8 EA201490233A EA201490233A EA201490233A8 EA 201490233 A8 EA201490233 A8 EA 201490233A8 EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A EA201490233 A EA 201490233A EA 201490233 A8 EA201490233 A8 EA 201490233A8
Authority
EA
Eurasian Patent Office
Prior art keywords
piperahin
arterolana
medical forms
stable medical
stable
Prior art date
Application number
EA201490233A
Other languages
English (en)
Russian (ru)
Other versions
EA201490233A1 (ru
Inventor
Арно Аппавоо Эноуз
Хариш Кумар Мадан
Сумит Мадан
Анупам Трехан
Пунеет Тьяги
Винод Кумар Арора
Саньюкта Бхаттачария
Арьюн Рой
Аннамдевара Балайи
Original Assignee
Ранбакси Лабораториз Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US13/183,119 priority Critical patent/US8664265B2/en
Priority to IN2703DE2011 priority
Priority to IN2156DE2012 priority
Application filed by Ранбакси Лабораториз Лимитед filed Critical Ранбакси Лабораториз Лимитед
Priority to PCT/IB2012/053614 priority patent/WO2013008218A1/en
Publication of EA201490233A1 publication Critical patent/EA201490233A1/ru
Publication of EA201490233A8 publication Critical patent/EA201490233A8/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06Antimalarials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y02A50/411
EA201490233A 2005-05-18 2012-07-13 Стабильные лекарственные формы артеролана и пиперахина EA201490233A8 (ru)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US13/183,119 US8664265B2 (en) 2005-05-18 2011-07-14 Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
IN2703DE2011 2011-09-19
IN2156DE2012 2012-07-12
PCT/IB2012/053614 WO2013008218A1 (en) 2011-07-14 2012-07-13 Stable dosage forms of arterolane and piperaquine

Publications (2)

Publication Number Publication Date
EA201490233A1 EA201490233A1 (ru) 2014-07-30
EA201490233A8 true EA201490233A8 (ru) 2015-01-30

Family

ID=47505579

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201490233A EA201490233A8 (ru) 2005-05-18 2012-07-13 Стабильные лекарственные формы артеролана и пиперахина

Country Status (10)

Country Link
EP (1) EP2731603A1 (es)
JP (1) JP2014522856A (es)
KR (1) KR20140053169A (es)
CN (1) CN103930107A (es)
AP (1) AP3777A (es)
AU (1) AU2012282077A1 (es)
CA (1) CA2850089A1 (es)
EA (1) EA201490233A8 (es)
MX (1) MX2014000463A (es)
WO (1) WO2013008218A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014132226A1 (en) 2013-02-28 2014-09-04 Ranbaxy Laboratories Limited Stable dispersible formulation of arterolane maleate and piperaquine and process of preparation thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6486199B1 (en) 2001-06-21 2002-11-26 Medicines For Malaria Venture Mmv International Centre Cointrin Spiro and dispiro 1,2,4-trioxolane antimalarials
US6906205B2 (en) 2002-06-21 2005-06-14 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trioxolane antimalarials
US6825230B2 (en) 2002-06-21 2004-11-30 Medicines For Malaria Venture Mmv Spiro and dispiro 1,2,4-trixolane antimalarials
WO2006123314A2 (en) * 2005-05-18 2006-11-23 Ranbaxy Laboratories Limited Stable dosage forms of spiro and dispiro 1,2,4-trioxolane antimalarials
BRPI0711585A2 (pt) * 2006-05-17 2011-11-16 Ranbaxy Lab Ltd terapia antimalárica

Also Published As

Publication number Publication date
AU2012282077A1 (en) 2014-01-30
WO2013008218A1 (en) 2013-01-17
AP201407413A0 (en) 2014-02-28
CN103930107A (zh) 2014-07-16
MX2014000463A (es) 2014-07-09
CA2850089A1 (en) 2013-01-17
EP2731603A1 (en) 2014-05-21
AP3777A (es) 2016-08-31
KR20140053169A (ko) 2014-05-07
JP2014522856A (ja) 2014-09-08
EA201490233A1 (ru) 2014-07-30

Similar Documents

Publication Publication Date Title
PH12017500281A1 (en) Pyrrolopyrimidine compounds used as tlr7 agonist
CY1118379T1 (el) Αναστολεις ιου ηπατιτιδας c
EA201591166A1 (ru) Ингибиторы аутотаксина
IN2014DN09434A (es)
MX360634B (es) 3-HALOALYLAMINE INHIBITORS REPLACED BY SSAO AND USE OF THE SAME.
EA035750B1 (ru) AQUATIC PHARMACEUTICAL COMPOSITION OF TAPENTADOL FOR Oral Administration
UA114856C2 (uk) Способи лікування із застосуванням похідних арилметоксіізоіндоліну
UA109010C2 (en) MORPHOLINOPYRIMIDINES AND THEIR APPLICATIONS IN THERAPY
MX2015010829A (es) Compuestos terapeuticos y sus usos.
MX2013001677A (es) STABLE FORMULATIONS OF LINACLOTIDA.
EA201500298A1 (ru) Алкоксипиразолы в качестве активаторов растворимой гуанилатциклазы
EA201300034A1 (ru) Фармацевтические композиции, содержащие иматиниб или его фармацевтически приемлемую соль, и способы их получения
EA201270741A1 (ru) Пероральные композиции и липофильные соли метилналтрексона
IN2015DN01119A (es)
BR112014006248A2 (pt) compostos de triazolopiridina como inibidores de pde10a
EA201490222A1 (ru) Комбинированные составы на основе дарунавира
UA109868C2 (ru) Соединения n-алкилтриазола как антагонисты лизофосфатидной кислоты (lpar)
EA201600434A1 (ru) Применение производных бензимидазолпролина
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
EA201590364A1 (ru) Применение орвепитанта, его солей и кристаллических форм и композиций, его содержащих, для лечения зуда
MX2013002948A (es) Composiciones farmaceuticas y nutraceuticas de acido abscisico.
UA117154C2 (uk) Антагоністи s1p3
BR112015008564A2 (pt) derivados de 6-aminoindol como antagonistas de canal trp
PH12015502703A1 (en) Pharmaceutical compositions
EA201490233A8 (ru) Стабильные лекарственные формы артеролана и пиперахина